Basis of preparation and statement of compliance - Significant investments in subsidiaries (Details) € in Thousands |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Feb. 24, 2026 |
Jan. 14, 2026 |
Jun. 30, 2026
EUR (€)
entity
|
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Basis of preparation and statement of compliance | |||||
| Number of entities being consolidated | entity | 2 | ||||
| Hepalys Pharma, Inc | |||||
| Basis of preparation and statement of compliance | |||||
| Proportion of ownership interest | 13.68% | 13.92% | 13.68% | 15.00% | 14.64% |
| Inventiva Inc. | |||||
| Basis of preparation and statement of compliance | |||||
| Percent of ownership interest | 100.00% | ||||
| Non-controlling interest | € | € 0 | ||||
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of entities being consolidated No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|